About Acid ceramidase
Acid ceramidase (ASAH1) is a protein
from Homo sapiens identified by UniProt accession
Q13510, 395 residues long.
MolForge cross-references it against 0 known binders and
1,455 disease associations.
Target properties
| Protein name | Acid ceramidase |
| UniProt accession | Q13510 |
| Gene | ASAH1 |
| Organism | Homo sapiens |
| Length | 395 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (1455)
Diseases linked to this target (Open Targets).
- Farber lipogranulomatosis · score 0.84
- spinal muscular atrophy-progressive myoclonic epilepsy syndrome · score 0.80
- Hereditary myoclonus - progressive distal muscular atrophy · score 0.79
- ASAH1-related disorders · score 0.48
- childhood epilepsy with centrotemporal spikes · score 0.45
- Rolandic epilepsy · score 0.45
- genetic disorder · score 0.41
- hydrops fetalis · score 0.37
- Intellectual disability · score 0.37
- Non-immune hydrops fetalis · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13510-F1 | alphafold | PREDICTED | 91.52 | — |
Amino-acid sequence (395 residues)
MPGRSCVALV LLAAAVSCAV AQHAPPWTED CRKSTYPPSG PTYRGAVPWY TINLDLPPYK RWHELMLDKA PVLKVIVNSL KNMINTFVPS GKIMQVVDEK LPGLLGNFPG PFEEEMKGIA AVTDIPLGEI ISFNIFYELF TICTSIVAED KKGHLIHGRN MDFGVFLGWN INNDTWVITE QLKPLTVNLD FQRNNKTVFK ASSFAGYVGM LTGFKPGLFS LTLNERFSIN GGYLGILEWI LGKKDVMWIG FLTRTVLENS TSYEEAKNLL TKTKILAPAY FILGGNQSGE GCVITRDRKE SLDVYELDAK QGRWYVVQTN YDRWKHPFFL DDRRTPAKMC LNRTSQENIS FETMYDVLST KPVLNKLTVY TTLIDVTKGQ FETYLRDCPD PCIGW
Explore Acid ceramidase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets